Analyst Maintains Buy Rating on Globe Life with $118 Price Target
Analyst John Barnidge affirms a Buy rating on Globe Life, targeting $118. Explore the latest insights and ratings for GL stock.
Analyst John Barnidge affirms a Buy rating on Globe Life, targeting $118. Explore the latest insights and ratings for GL stock.
Learn about Medicare's initial enrollment period, how it affects new enrollees like Jenny turning 65, and the necessary steps to take for smooth enrollment without penalties.
Aetna unveils its comprehensive 2025 Medicare product offerings, featuring $0 premium plans, diverse options for Medicare beneficiaries, and a commitment to quality healthcare services.
Explore the important differences between Medicare Advantage and Medicare Supplement plans to ensure informed healthcare decisions. Case study of a reader's experience warns of misconceptions about coverage and costs.
Blue Cross and Blue Shield of Illinois announces plans to acquire Cigna Healthcare’s Medicare Advantage and related businesses, enhancing service quality and provider support.
Essence Healthcare expands to Chicago, offering Medicare Advantage plans focused on quality and access for beneficiaries. Explore patient-centered services starting this fall.
Humana reports a significant drop in Medicare Advantage Star Ratings for 2025, impacting future revenues and leading to plan exits in several counties.
Ambetter from Coordinated Care will provide a variety of affordable health insurance plans for residents in Washington during the 2025 open enrollment period.
The CMS faces criticism for failing to address billions in Medicare Advantage overpayments. Investigate how political influence impacts oversight and what this means for seniors.